Feasibility of Outpatient Care After Manual Compression in Patients Treated for Peripheral Arterial Disease by Endovascular Technique With 5F Sheath Femoral Approach
FREEDOM OP
1 other identifier
interventional
116
1 country
10
Brief Summary
Over the past years, arterial closure systems have tended to replace manual compression to ensure hemostasis at femoral artery puncture points. Arterial closure systems reduce hemostasis and patient immobilization times, thus enabling early resumption of walking. These devices have contributed extensively to the development of outpatient stays for cardiology, vascular and neuro-radiology procedures. According to certain studies however, it would appear that arterial closure devices do not present any greater benefits than manual compression in terms of hemostasis and complications. Moreover, the use of increasingly small diameter instruments would tend to render manual compression sufficient. Finally, the use of these devices generates additional costs. The purpose of our prospective study is to evaluate the feasibility and safety of same-day discharge after manual compression in patients treated for peripheral artery disease by endovascular technique with 5F sheath.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2017
Typical duration for not_applicable
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2017
CompletedFirst Posted
Study publicly available on registry
June 14, 2017
CompletedStudy Start
First participant enrolled
September 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2019
CompletedNovember 21, 2019
November 1, 2019
2 years
June 7, 2017
November 20, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Total in-hospital admission rate
Total in-hospital admission rate includes unplanned overnight surveillance and re-hospitalization rate at 1 month.
1 month
Secondary Outcomes (14)
Death (all causes) at 1 month.
1 month
Unplanned overnight surveillance rate
1 month
Re-hospitalization after discharge during M1
1 month
Occurrence of major events during the perioperative period (H0 to M1)
1 month
Occurrence of major punctured femoral artery events during the perioperative period (H0 to M1)
1 month
- +9 more secondary outcomes
Study Arms (1)
Manual puncture point compression
OTHERManual puncture point compression following a diagnostic or therapeutic procedure by endovascular technique involving retrograde femoral puncture point with 5F guide catheter
Interventions
Manual puncture point compression following a diagnostic or therapeutic procedure by endovascular technique involving retrograde femoral puncture point with 5F guide catheter
Eligibility Criteria
You may qualify if:
- Age \> 18 years,
- Endovascular treatment by stent or drug coating balloon 5F and 0.035 compatible
- Femoral approach
- Outpatient hospitalization
- Manual compression at puncture site
- Rutherford 2 to 5
- Patient affiliated with a social security scheme
- Patient's signed informed consent form
You may not qualify if:
- Under-age patient
- Patient of age, but under legal guardianship or care
- Contraindication to endovascular treatment
- Use of a 6F or greater sheath
- Radial or brachial puncture
- Acute ischemia
- Anticoagulant treatment or hemostasis disorder
- Allergy to Elastoplast® type adhesive strips
- Life expectancy of less than one month
- Refusal of patient to participate in the study
- Participation in another therapeutic trial
- Pregnant woman, lactating women
- Patients do not understand the French language or unfit for proposed follow in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
CHU de Besançon
Besançon, France
CHU de Bordeaux
Bordeaux, France
AP-HP, Hôpital Ambroise Paré
Boulogne-Billancourt, France
CHU de Clermont Ferrand
Clermont-Ferrand, France
CHU de DIJON
Dijon, France
Clinique de Fontaine-Les- Dijon
Dijon, France
Nantes University Hospital
Nantes, France
AP-HP, Hôpital Européen Georges Pompidou
Paris, France
Institut Mutualiste Montsouris
Paris, France
Clinique de l'Europe
Rouen, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2017
First Posted
June 14, 2017
Study Start
September 27, 2017
Primary Completion
October 10, 2019
Study Completion
October 10, 2019
Last Updated
November 21, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share